Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Lift Toronto 2023 Conference & Expo: Lifting the Rapidly Expanding Cannabis Industry & Community

Cannabis industry leaders, entrepreneurs, policymakers, service providers and consumers are all invited to attend the Lift Toronto 2023 Conference & Expo to be held at Metro Toronto Convention Centre from June 1-3, 2023. The advocacy-oriented, strategy-focused Lift Cannabis Business Conference (“LCBC”) on June 1st kicks off the three-day event and is dedicated to discussing best […]

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Targets Beijing Influence Over Global Rare Earth Industry; Doubles Down on its North American Investment

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a company with a vision and plan to become a leading advanced technology company, providing best-in-class metal separation products and services to the mining and mineral extraction industry, is doubling down on its North American operations, in light of a gradual but important shift away from Beijing’s influence […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Dosing in Human Oral Nicotine Study, Hopes to Facilitate More Satisfying Experience with DehydraTECH(TM)-Processed Oral Nicotine

Lexaria Bioscience (NASDAQ), a global innovator in drug delivery platforms, recently announced that the dosing of the targeted 36 subjects in its human clinical oral nicotine study NIC-H22-1 had been completed. In the meantime, the company has already commenced sample and data analysis and expects to report the findings as soon as possible (https://ibn.fm/7bhFu). NIC-H22-1 […]

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Continues to Grow Through Regional Expansion and Cross-Market Opportunities

With its multidimensional benefits, including the potential to reduce greenhouse gas emissions, reuse waste materials, and power transportation, Renewable Natural Gas (“RNG”) is making headlines in the sustainability space, emerging as a promising solution for tackling the growing environmental challenges. EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), an innovative Canadian developer of the RNG infrastructure platform, […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pivotal Milestones Concerning DehydraTECH(TM) Technology, Including IND Application Plans

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is improving how active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules through its patented DehydraTECH(TM) technology. DehydraTECH can be used with a wide range of product formats, including pharmaceuticals, neutraceuticals, consumer […]

CISO Global Inc. (NASDAQ: CISO) Earns Overweight Rating in Latest Cantor Fitzgerald Equity Research Report

A recent Cantor Fitzgerald equity research report is high on CISO Global (NASDAQ: CISO), formerly Cerberus Cyber Sentinel Corp., a leading provider of global cybersecurity and compliance. Noting that the company is strategically positioned to fill the cybersecurity talent shortage gap, Cantor Research gave CISO an overweight rating and a $2 price target (https://nnw.fm/EP1WX). “Reiterate […]

Electronic Servitor Publication Network Inc. (XESP) Is ‘One to Watch’

Electronic Servitor Publication Network (OTCQB: XESP) is a digital engagement company offering a managed service which provides digital activation and engagement solutions to companies that seek to optimize their growth. Its managed service is powered by a proven, proprietary technology – the Digital Engagement Engine(TM). This technology provides intelligent interaction management, dynamic content provisioning, and a […]

Genprex Inc. (NASDAQ: GNPX) Research Collaborators Present Positive Preclinical Data at American Association of Cancer Research 2023 Annual Meeting

Genprex (NASDAQ: GNPX), A cutting-edge gene therapy company striving to improve the lives of cancer and diabetes patients through the creation of groundbreaking treatments, announced last month that its research collaborators presented positive preclinical data for the NPRL2 gene, which is a tumor suppressor gene. The presentation was given at the 2023 American Association of […]

 

From Our Blog

The Software Premium: How SPARC AI Is Betting That Code, Not Airframes, Decides the Next Drone War

August 11, 2026

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. For decades, military advantage came from building better aircraft. Today’s battlefield increasingly rewards something different: making inexpensive aircraft smarter. As drones become cheaper and more disposable, software is becoming the primary source of military advantage. A single guided munition […]

Rotate your device 90° to view site.